BRCA1 and colorectal carcinoma: The proportion of BRCA1 mutations was increased in CRC patients (OR = 1.48, 95% CI = 1.11–1.99, P = 0.009), with no statistical heterogeneity (I2 = 5%) (Fig. 2).